Nasdaq plans to delist Windtree Therapeutics for violating minimum bid price rules. Windtree struggles with financial instability, possibly linked to its BNB investments. Continue Reading:Windtree Faces Delisting as Nasdaq Tightens its Rules The post Windtree Faces Delisting as Nasdaq…